Researchers from NVIDIA and King’s College London have collaborated on a new federated learning system specifically designed for the interpretation of medical images.

“We’ve been telling patients that even if these injections don’t relieve your pain, they’re not going to hurt you, but now we suspect that this is not necessarily the case,” said Ali Guermazi, MD, PhD, a professor of radiology at Boston University’s School of Medicine. 

Sky-high drug prices are a huge issue for many Americans who can’t pay for necessary medications, and 78% feel the federal government should be able to negotiate better prices.

STEMI is increasingly prevalent among a growing population of patients in their nineties, according to a study published in the American Journal of Cardiology Oct. 11.

RSNA 2019 attendees wishing to see radiology through the eyes of an astute nonradiologist will find what they’re looking for when Abraham Verghese, MD, takes the mic at the opening session. 

The newest AI-based imaging processing software from Subtle Medical has received FDA clearance.

RSNA President Jackson, a breast specialist whose other appointments include executive director of the American Board of Radiology and Eugene C. Klatte Professor Emeritus at Indiana University School of Medicine, took RBJ’s questions on her upcoming talk and other topics. 

Using sex-specific thresholds for high-sensitivity cardiac troponin I assays identified five times more heart attacks in women in a recent study of patients with suspected ACS, but major disparities persisted when it came to treating MIs.

Researchers found measurements performed with their full-scale airway network flow model based on CT imaging data compared similarly to measurements derived from functional lung imaging. In addition to improving COPD analysis, the platform can help shed light on many forms of lung disease.

Digital health companies continued raking in venture capital during the first three quarters of 2019, according to a new report from Mercom Capital Group, but the number of deals and the value is about 10% lower year over year.